Biotech bearish stocks: Prothena Corporation (NASDAQ:PRTA), Oncomed Pharmaceuticals (NASDAQ:OMED), Enanta Pharmaceuticals (NASDAQ:ENTA), Vanda Pharmaceuticals (NASDAQ:VNDA)

Shares of Prothena Corp PLC (NASDAQ:PRTA) were the recipient of a large increase in short interest in the month of January. As of March 14th, there was short interest totaling 824,645 shares, an increase of 35.0% from the February 28th total of 610,797 shares, AnalystRatingsNetwork.com reports. Prothena Corporation PLC (NASDAQ:PRTA) stock performance was -13.98% in last session and finished the day at $29.60. Traded volume … Continue reading Biotech bearish stocks: Prothena Corporation (NASDAQ:PRTA), Oncomed Pharmaceuticals (NASDAQ:OMED), Enanta Pharmaceuticals (NASDAQ:ENTA), Vanda Pharmaceuticals (NASDAQ:VNDA)

Colin Pettis04/0704/07

Hot Stocks : Comcast (NASDAQ:CMCSA), Annaly Capital Management (NYSE:NLY), Enanta Pharmaceuticals. (NASDAQ:ENTA), Cloud Peak Energy Inc. (NYSE:CLD), EveryWare Global (NASDAQ:EVRY),

Comcast Corporation (NASDAQ:CMCSA) has denied the allegations, calling them absolutely inaccurate. Comcast’s Vice President of Internet Services in Technology, Jason Livinghood, said the company’s internal investigation found no evidence to substantiate the claims made by DeepDotWeb. He further added that the company had “no policy against the use of Tor,” and that its customer service agents never asked users about their browsing history. Comcast Corporation … Continue reading Hot Stocks : Comcast (NASDAQ:CMCSA), Annaly Capital Management (NYSE:NLY), Enanta Pharmaceuticals. (NASDAQ:ENTA), Cloud Peak Energy Inc. (NYSE:CLD), EveryWare Global (NASDAQ:EVRY),

Jason Knox09/17

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively. This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by … Continue reading Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz08/2608/26

Trending Stocks: Enanta Pharmaceuticals (NASDAQ:ENTA), Chevron Corporation (NYSE:CVX), Corium International, Inc. (NASDAQ:CORI), Heritage Oaks Bancorp (NASDAQ:HEOP), Fabrinet (NYSE:FN)

Enanta Pharmaceuticals (NASDAQ:ENTA) issued its quarterly earnings data on Monday. The company reported $2.61 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.67 by $0.94. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) belongs to Healthcare sector. Its weekly performance is 4.49%. On last trading day company shares ended up $39.13. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) distance from 50-day simple moving average (SMA50) is -2.96%. Chevron Corporation (NYSE: CVX) reported … Continue reading Trending Stocks: Enanta Pharmaceuticals (NASDAQ:ENTA), Chevron Corporation (NYSE:CVX), Corium International, Inc. (NASDAQ:CORI), Heritage Oaks Bancorp (NASDAQ:HEOP), Fabrinet (NYSE:FN)

Mark Doerr08/13